The Medicines Company Is Almost Ready To Celebrate Angiomax Patent Term Extension
This article was originally published in The Pink Sheet Daily
Executive Summary
Studies of additional indications for the product may resume as the Patent and Trademark Office assesses the potential length of the extension, which could protect the product until mid-2015.